Hyzetimibe is a cholesterol absorption inhibitor that functions by targeting the Niemann-Pick C1-Like 1 (NPC1L1) protein in the small intestine, thereby reducing the absorption of dietary and biliary cholesterol… Read more








Hyzetimibe is a cholesterol absorption inhibitor that functions by targeting the Niemann-Pick C1-Like 1 (NPC1L1) protein in the small intestine, thereby reducing the absorption of dietary and biliary cholesterol to manage hyperlipidemia. This category encompasses a comprehensive range of Hyzetimibe-related compounds, including high-purity reference standards, process-related impurities, and key metabolites such as Hyzetimibe-glucuronide. Laboratories utilize these materials for critical analytical functions, including impurity profiling and the validation of analytical methods during drug development and regulatory testing. Additionally, stable isotope labelled compounds, such as deuterated variants, serve as essential internal standards for mass spectrometry applications, enabling precise quantification and trace analysis in complex biological or chemical matrices. These reference materials facilitate robust quality control throughout the pharmaceutical manufacturing and research workflows, ensuring compliance with established analytical standards.